Could a common supplement shield breast cancer patients from radiation burns?

NCT ID NCT07256119

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking alpha lipoic acid, a common antioxidant supplement, can prevent or reduce skin irritation caused by radiation therapy in breast cancer patients. Researchers will enroll 40 women with early-stage breast cancer who are scheduled for radiation. The goal is to see if the supplement lowers the chance of developing radiation dermatitis and reduces its severity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zagazig University Hospitals

    RECRUITING

    Zagazig, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.